Levy L D, Durie P R, Pencharz P B, Corey M L
J Pediatr. 1985 Aug;107(2):225-30. doi: 10.1016/s0022-3476(85)80130-x.
Fourteen patients aged 4.9 to 21.5 years with cystic fibrosis and moderate to severe lung disease, malnutrition, or growth failure were given nocturnal supplemental feeding by gastrostomy tube. Mean follow-up was for 1.1 years (range 0.8 to 2.78 years). Patients were studied to observe the effect of nutritional support on body composition, growth, pulmonary function, and quality of life. A contemporary group of patients with CF was retrospectively pair matched to the study group. The supplemental feeding resulted in positive changes in body composition and in growth velocity. Weight, as a percentage of standard in the control group, declined by 3% over 1 year, whereas it increased by 2% in the treatment group (P less than 0.05). Pulmonary function, assessed as a percent of predicted FVC and FEV1, did not change significantly in the treatment group over 1.1 years, whereas FVC declined by 12% (P less than 0.01) and FEV1 declined by 13% (P less than 0.01) in the control group. There was a marked increase in patient ability to participate in activities of daily living, even in those patients in whom pulmonary function deteriorated during the study.
14名年龄在4.9至21.5岁之间、患有囊性纤维化且有中度至重度肺部疾病、营养不良或生长发育迟缓的患者通过胃造口管接受夜间补充喂养。平均随访时间为1.1年(范围0.8至2.78年)。对患者进行研究以观察营养支持对身体成分、生长发育、肺功能和生活质量的影响。一组当代囊性纤维化患者与研究组进行回顾性配对。补充喂养使身体成分和生长速度出现了积极变化。对照组体重占标准体重的百分比在1年内下降了3%,而治疗组则增加了2%(P<0.05)。在1.1年的时间里,治疗组以预测的用力肺活量(FVC)和第1秒用力呼气量(FEV1)的百分比评估的肺功能没有显著变化,而对照组的FVC下降了12%(P<0.01),FEV1下降了13%(P<0.01)。患者参与日常生活活动的能力有显著提高,即使是在研究期间肺功能恶化的患者中也是如此。